Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CDI Blood Parameter Monitoring System 550

K-Number: K182110 · 2018-11-02

Decision Date2018-11-02
Product CodeDRY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CDI Blood Parameter Monitoring System 550 is a medical device manufactured by Terumo Cardiovascular Systems Corporation. It received FDA 510(k) clearance on 2018-11-02 under approval number K182110. The device is classified under product code DRY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CDI Blood Parameter Monitoring System 550?

CDI Blood Parameter Monitoring System 550 is a medical device that received FDA 510(k) clearance on 2018-11-02. It is manufactured by Terumo Cardiovascular Systems Corporation. The 510(k) number is K182110.

When was CDI Blood Parameter Monitoring System 550 approved by the FDA?

CDI Blood Parameter Monitoring System 550 received FDA 510(k) clearance on 2018-11-02, under approval number K182110.

What company makes CDI Blood Parameter Monitoring System 550?

CDI Blood Parameter Monitoring System 550 is manufactured by Terumo Cardiovascular Systems Corporation.

What is the FDA product code for CDI Blood Parameter Monitoring System 550?

The FDA product code for CDI Blood Parameter Monitoring System 550 is DRY.

Related Clinical Trials

Related PubMed Literature

Other Devices by Terumo Cardiovascular Systems Corporation

View all 10 devices →

Related Devices (Code: DRY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.